Find policies, billing codes, payers, states, and providers
CPT 87207: Slide Analysis for Inclusion Bodies, Primary Source
CPT code 87207 represents a laboratory technical procedure in which a trained analyst examines a primary-source specimen mounted on a slide to detect inclusion bodies. This microscopic diagnostic service supports identification of intracellular pathogens or characteristic cellular changes that inform clinical diagnosis and subsequent treatment decisions. Nationally, payers and laboratories rely on such standardized procedural codes to ensure consistent billing, clinical communication, and quality measurement for pathologic and infectious disease testing.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for use of 87207, common service settings, and how this code relates to adjacent laboratory services. The publication summarizes payer coverage patterns and typical billing considerations tied to technical laboratory microscopy for primary-source specimens.
This report also outlines relationships to related laboratory procedures used for culture, parasite identification, and smear interpretation, and provides benchmarks and policy-relevant context for coding and billing teams. Clinical and administrative readers will gain clarity on when 87207 is the relevant procedure code for slide-based inclusion body analysis and how it integrates with laboratory workflows and reporting practices.
Customize your policy alerts
Sign up for cpt 87207 policy alerts
Get alerted when payer policies referencing 87207 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 87207 describes a technical laboratory test in which a lab analyst examines a specimen on a slide from a primary source to identify inclusion bodies. The service involves preparing and analyzing a direct smear or slide-mounted specimen to detect characteristic intracellular or intranuclear inclusions that support diagnosis of infectious or inflammatory processes.
Service type: Clinical laboratory diagnostic test (microscopic slide analysis)
Typical site of service: Clinical laboratory or hospital laboratory (on-site laboratory processing and microscopy)
National Reimbursement Benchmarks
Across national payers, Medicare’s mean rate of $18.2 sits below BUCA’s average commercial mean of $31.7, indicating that BUCA reimburses substantially higher on average for CPT 87207 than Medicare. Blue Cross Blue Shield’s mean of $46.5 and Cigna’s mean of $17.1 further highlight commercial variability, with BCBS above BUCA and Cigna closer to Medicare. UnitedHealth Group ($9.0) and Aetna ($9.8) cluster lower among commercial payers, producing a broad span of typical commercial reimbursements around the Medicare baseline.
Dispersion measured by the interquartile range (P75–P25) is widest for Blue Cross Blue Shield at $33.9 and relatively wide for BUCA at $22.3, signaling considerable variability in commercially negotiated rates. The tightest spreads are Medicare at $1.0 (P75–P25 = $1) and UnitedHealth Group at $7.8, with Aetna ($9.6) and Cigna ($14.7) in between. This suggests some payers deliver consistent rates around their medians while others have much broader negotiated ranges.